Analyze Diet
Pathogens (Basel, Switzerland)2026; 15(3); 258; doi: 10.3390/pathogens15030258

Rift Valley Fever Virus Exposure in Camels and Horses Across Northern Nigeria Livestock Markets.

Abstract: Rift Valley Fever (RVF) is a neglected vector-borne zoonotic disease of significant veterinary and public health concern in Sub-Saharan Africa. This study investigated the seroprevalence of Rift Valley Fever Virus (RVFV) exposure and associated risk factors among camels and horses marketed in northern Nigeria. A total of 1117 animals were sampled, comprising camels (812) and horses (305), across three major livestock markets (Maigatari, Maiduguri, and Illela). The overall seroprevalence was 18.8% (95% CI: 16.6-21.2%), with a striking six-fold disparity: camels showed a prevalence of 24.4% (95% CI: 21.6-27.4%), while horses exhibited only 3.9% (95% CI: 2.1-7.0%). Significant geographic clustering was observed, with Illela camels recording the highest prevalence (34.8%) compared to those in Maigatari (20.3%) and Maiduguri (20.2%). There were no significant associations with age or sex among camels. However, in horses, females were significantly more likely to test positive than males (OR = 0.27, 95% CI: 0.07-0.97). These findings demonstrate endemic RVFV circulation in Nigerian livestock, highlighting species- and location-specific differences, and underscore the zoonotic risks within regional and transboundary livestock trade networks.
Publication Date: 2026-02-28 PubMed ID: 41901711PubMed Central: PMC13029466DOI: 10.3390/pathogens15030258Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Rift Valley Fever Virus (RVFV) exposure was studied in camels and horses from livestock markets in northern Nigeria, revealing a significant presence of the virus in camels and lower exposure in horses, with notable differences based on market location and species.

Study Background and Objective

  • Rift Valley Fever (RVF) is a disease transmitted by mosquitoes and affects both animals and humans in Sub-Saharan Africa.
  • The research aimed to determine how common RVFV exposure is among two types of livestock—camels and horses—in northern Nigeria and to identify factors linked to such exposure.
  • This is important because RVF can impact public health and livestock productivity, and the movement of animals across borders can spread the virus.

Methodology

  • Sample Collection:
    • A total of 1117 animals were sampled: 812 camels and 305 horses.
    • Animals were obtained from three major livestock markets: Maigatari, Maiduguri, and Illela.
  • Testing:
    • Seroprevalence testing was conducted to detect antibodies indicating past exposure to RVFV.
  • Data Analysis:
    • Prevalence rates were estimated with 95% confidence intervals (CIs).
    • Statistical analysis was used to identify significant differences by species, location, age, and sex.

Key Findings

  • Overall, 18.8% of the sampled animals had been exposed to RVFV.
  • Species Differences:
    • Camels showed a substantially higher exposure rate (24.4%) compared to horses (3.9%).
    • The disparity suggests that camels are more susceptible or more frequently infected by RVFV than horses in this region.
  • Geographic Variation:
    • Significant clustering of RVFV exposure was observed based on market location.
    • Illela had the highest prevalence among camels at 34.8%, whereas Maigatari and Maiduguri showed around 20% prevalence.
  • Demographic Factors:
    • Among camels, neither age nor sex was significantly associated with RVFV exposure.
    • In horses, female animals were more likely to be seropositive than males, indicating possible sex-related vulnerability or exposure differences.

Significance and Implications

  • Endemic Circulation:
    • The presence of RVFV antibodies in both species, especially camels, indicates ongoing virus circulation in northern Nigerian livestock.
  • Zoonotic Risk:
    • Since RVF is zoonotic, the findings highlight a risk that people working with or around these animals may become infected.
    • Understanding species-specific infection patterns can help target public health and veterinary interventions.
  • Trade and Disease Spread:
    • Livestock markets serve as nodes in regional and transboundary animal trade networks, facilitating potential spread of RVFV.
    • Identification of high-prevalence locations supports improved surveillance and control measures in these areas.

Conclusions

  • The study reveals notable differences in RVFV exposure between camels and horses, with camels acting as a potential reservoir or indicator species.
  • Geographic clustering of RVFV exposure suggests localized factors influencing virus transmission that warrant further investigation.
  • These insights can guide improved monitoring, veterinary care, and public health policies to mitigate RVF impacts in Nigeria and across neighboring regions where livestock trade is common.

Cite This Article

APA
Ehizibolo DO, Oyekan O, Mkpuma N, Haliru H, Garba I, Turaki IZ, Williams EE, Danmarwa A, Mohammed A, Muhammad MA, Abubakar M, Brown C, Faburay B. (2026). Rift Valley Fever Virus Exposure in Camels and Horses Across Northern Nigeria Livestock Markets. Pathogens, 15(3), 258. https://doi.org/10.3390/pathogens15030258

Publication

ISSN: 2076-0817
NlmUniqueID: 101596317
Country: Switzerland
Language: English
Volume: 15
Issue: 3
PII: 258

Researcher Affiliations

Ehizibolo, David Odion
  • National Veterinary Research Institute, Vom 930001, Plateau State, Nigeria.
Oyekan, Olumuyiwa
  • National Veterinary Research Institute, Vom 930001, Plateau State, Nigeria.
Mkpuma, Nicodemus
  • National Veterinary Research Institute, Vom 930001, Plateau State, Nigeria.
Haliru, Habibu
  • National Veterinary Research Institute, Vom 930001, Plateau State, Nigeria.
Garba, Ibrahim
  • National Veterinary Research Institute, Vom 930001, Plateau State, Nigeria.
Turaki, Isa Zayyad
  • National Veterinary Research Institute, Vom 930001, Plateau State, Nigeria.
Williams, Elizabeth Ene
  • National Veterinary Research Institute, Vom 930001, Plateau State, Nigeria.
Danmarwa, Agom
  • National Veterinary Research Institute, Vom 930001, Plateau State, Nigeria.
Mohammed, Abdullahi
  • Veterinary Department, Ministry of Agriculture and Natural Resources, Dutse 720101, Jigawa State, Nigeria.
Muhammad, Musa Abdullahi
  • Veterinary Department, Ministry of Agriculture and Natural Resources, Dutse 720101, Jigawa State, Nigeria.
Abubakar, Mansur
  • Department of Veterinary Services, Ministry of Animal Health and Fisheries, Sokoto 840103, Sokoto State, Nigeria.
Brown, Corrie
  • LifeStock International, Athens, GA 30606, USA.
Faburay, Bonto
  • Foreign Animal Disease Diagnostic Laboratory, National Veterinary Services Laboratories, National Bio and Agro-Defense Facility, United State Department of Agriculture, Manhattan, KS 66505, USA.

MeSH Terms

  • Animals
  • Camelus / virology
  • Rift Valley Fever / epidemiology
  • Rift Valley Fever / virology
  • Horses
  • Nigeria / epidemiology
  • Rift Valley fever virus / immunology
  • Seroepidemiologic Studies
  • Female
  • Male
  • Antibodies, Viral / blood
  • Risk Factors
  • Zoonoses / epidemiology
  • Zoonoses / virology
  • Livestock / virology
  • Horse Diseases / epidemiology
  • Horse Diseases / virology

Conflict of Interest Statement

The authors declare no conflicts of interest.

References

This article includes 42 references
  1. Davies FG, Martin V. Recognising Rift Valley Fever. Vet. Ital. 2006;42:31–53.
    pubmed: 20429078
  2. Adams MJ, Lefkowitz EJ, King AMQ, Harrach B, Harrison RL, Knowles NJ, Kropinski AM, Krupovic M, Kuhn JH, Mushegian AR. Changes to taxonomy and the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses (2017). Arch. Virol. 2017;162:2505–2538.
    doi: 10.1007/s00705-017-3358-5pubmed: 28434098google scholar: lookup
  3. Pepin M, Bouloy M, Bird BH, Kemp A, Paweska J. Rift Valley fever virus (Bunyaviridae: Phlebovirus): An update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet. Res. 2010;41:61.
    doi: 10.1051/vetres/2010033pmc: PMC2896810pubmed: 21188836google scholar: lookup
  4. . Rift Valley Fever: An Emerging Human and Animal Problem. WHO; Geneva, Switzerland: 1982. 69p WHO Offset Publication No. 63.
    pubmed: 7102093
  5. Meegan JM. The Rift Valley fever epizootic in Egypt: 1977–1978. I. Description of the epizootic and virological studies. Trans. R. Soc. Trop. Med. Hyg. 1979;73:618–723.
    doi: 10.1016/0035-9203(79)90004-Xpubmed: 538803google scholar: lookup
  6. Hoogstraal H, Meegan JM, Khalil GM, Adham FK. The Rift Valley fever epizootic in Egypt, 1977–1978. II. Ecological and entomological studies. Trans. R. Soc. Trop. Med. Hyg. 1979;73:624–629.
    doi: 10.1016/0035-9203(79)90005-1pubmed: 44038google scholar: lookup
  7. Nanyingi MO, Munyua P, Kiama SG, Muchemi GM, Thumbi SM, Bett AO, Bett B, Murithi RM, Njenga MK. A systematic review of Rift Valley fever epidemiology 1931–2014. Infect. Ecol. Epidemiol. 2015;5:28025.
    doi: 10.3402/iee.v5.28024pmc: PMC4522434pubmed: 26234531google scholar: lookup
  8. Linthicum KJ, Britch SC, Anyamba A. Rift Valley fever: An emerging mosquito-borne disease. Annu. Rev. Entomol. 2016;61:395–415.
  9. Njenga MK, Bett B. Rift Valley fever virus—How and where the virus is maintained during inter-epidemic periods. Curr. Clin. Microbiol. Rep. 2019;6:18–24.
    doi: 10.1007/s40588-018-0110-1google scholar: lookup
  10. Rich KM, Wanyoike F. An assessment of the regional and national socio-economic impacts of the 2007 Rift Valley fever outbreak in Kenya. Am. J. Trop. Med. Hyg. 2010;83:52–57.
    doi: 10.4269/ajtmh.2010.09-0291pmc: PMC2913501pubmed: 20682906google scholar: lookup
  11. Chengula AA, Mdegela RH, Kasanga CJ. Socio-economic impact of Rift Valley fever to pastoralists and agro-pastoralists in Arusha, Manyara and Morogoro regions in Tanzania. SpringerPlus 2013;2:549.
    doi: 10.1186/2193-1801-2-549pmc: PMC3825084pubmed: 24255846google scholar: lookup
  12. Mansfield KL, Banyard AC, McElhinney L, Johnson N, Horton DL, Hernández-Triana LM, Fooks AR. Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe. Vaccine 2015;33:5520–5531.
    doi: 10.1016/j.vaccine.2015.08.020pubmed: 26296499google scholar: lookup
  13. Jansen van Vuren P, Kgaladi J, Patharoo V, Ohaebosim P, Msimang V, Nyokong B, Paweska JT. Human cases of Rift Valley fever in South Africa, 2018. Vector Borne Zoonotic Dis. 2018;18:713–715.
    doi: 10.1089/vbz.2018.2357pmc: PMC6276270pubmed: 30183525google scholar: lookup
  14. Digoutte JP, Peters CJ. General aspects of the 1987 Rift Valley fever epidemic in Mauritania. Res. Virol. 1989;140:27–30.
    doi: 10.1016/S0923-2516(89)80081-0pubmed: 2711042google scholar: lookup
  15. Lagare A, Fall G, Ibrahim A, Ousmane S, Sadio B, Abdoulaye M, Alhassane A, Mahaman AE, Issaka B, Sidikou F. First occurrence of Rift Valley fever outbreak in Niger, 2016. Vet. Med. Sci. 2019;5:70–78.
    doi: 10.1002/vms3.135pmc: PMC6376139pubmed: 30411868google scholar: lookup
  16. Balkhy HH, Memish ZA. Rift Valley fever: An uninvited zoonosis in the Arabian Peninsula.. Int. J. Antimicrob. Agents 2003;21:153–157.
    doi: 10.1016/S0924-8579(02)00295-9pubmed: 12615379google scholar: lookup
  17. Ferguson W. Identification of Rift Valley fever in Nigeria.. Bull. Epizoot. Dis. Afr. 1959;7:317–318.
  18. Fagbami AH, Tomori O, Kemp GE. Survey of Nigerian Domestic and Wild Animals for Serum Neutralizing Antibody to Indigenous Rift Valley Fever Virus.. Nig. Vet. J. 1973;2:45–48.
  19. Tomori O. Rift Valley fever virus infection in man in Nigeria.. J. Med. Virol. 1980;5:343–350.
  20. Tomori O, Fabiyi A, Sorungbe A, Smith A, McCormick JB. Viral haemorrhagic fever antibodies in Nigerian populations.. Am. J. Trop. Med. Hyg. 1988;38:407–410.
    doi: 10.4269/ajtmh.1988.38.407pubmed: 3128130google scholar: lookup
  21. Olaleye OD, Tomori O, Ladipo MA, Schmitz HZ. Rift Valley fever in Nigeria: Infections in humans.. Rev. Sci. Tech. 1996;15:923–935.
    doi: 10.20506/rst.15.3.967pubmed: 9025142google scholar: lookup
  22. Olaleye OD, Tomori O, Schmitz H. Rift Valley fever in Nigeria: Infections in domestic animals.. Rev. Sci. Tech. 1996;15:937–946.
    doi: 10.20506/rst.15.3.966pubmed: 9025143google scholar: lookup
  23. Bukbuk DN, Fukushi S, Tani H, Yoshikawa T, Taniguchi S, Iha K, Fukuma A, Shimojima M, Morikawa S, Saijo M. Development and validation of serological assays for viral hemorrhagic fevers and determination of the prevalence of Rift Valley fever in Borno State, Nigeria.. Trans. R. Soc. Trop. Med. Hyg. 2014;108:768–773.
    doi: 10.1093/trstmh/tru163pmc: PMC7107251pubmed: 25344695google scholar: lookup
  24. Opayele AV, Ndiana LA, Odaibo GN, Olaleye DO. Serological evidence of Rift Valley fever virus infection in slaughtered ruminants in Nigeria.. J. Immunoass. Immunochem. 2019;40:367–377.
    doi: 10.1080/15321819.2019.1609498pubmed: 31081465google scholar: lookup
  25. Atuman YJ, Kudi CA, Abdu PA, Okubanjo OO, Wungak Y, Ularamu HG, Abubakar A. Serological Evidence of Antibodies to Rift Valley Fever Virus in Wild and Domestic Animals in Bauchi State, Nigeria.. Vet. Med. Int. 2022;2022:6559193.
    doi: 10.1155/2022/6559193pmc: PMC8942677pubmed: 35340539google scholar: lookup
  26. Oragwa AO, Oragwa FC, Oluwayelu DO. Serologic Evidence of Silent Rift Valley Fever Virus Infection among Occupationally Exposed Persons in Northern Nigeria.. J. Infect. Dev. Ctries. 2022;16:881–887.
    doi: 10.3855/jidc.15367pubmed: 35656961google scholar: lookup
  27. Ehizibolo DO, Oyekan O, Mkpuma N, Gado DA, Turaki IZ, Haliru H, Garba I, Williams EE, Kennedy S, Abdullahi A. Seroprevalence of Crimean-Congo Hemorrhagic Fever and Rift Valley Fever Viruses Among Ruminants in Nigeria: A Descriptive Epizootiological Analysis.. Pathogens 2025;14:1219.
    doi: 10.3390/pathogens14121219pmc: PMC12736218pubmed: 41471175google scholar: lookup
  28. Oragwa AO, Obishakin ET, Oluwayelu DO. Molecular Detection and Characterization of Rift Valley Fever Virus in Arthropod Vectors in Nigeria.. Microbe 2024;5:100198.
  29. Ezeifeka GO, Umoh JU, Belino ED, Ezeokoli CD. A serological survey for Rift Valley fever antibody in food animals in Kaduna and Sokoto States of Nigeria.. Int. J. Zoonoses 1982;9:147–151.
    pubmed: 6820360
  30. Musa HI, Kudi CA, Gashua MM, Muhammad AS, Tijjani AO, Saidu AS, Mohammed S, Jajere SM, Adamu SG. Survey of antibodies to Rift Valley fever virus and associated risk factors in one-humped camels (Camelus dromedarius) slaughtered in Maiduguri abattoir, Borno State, Nigeria.. Trop. Anim. Health Prod. 2021;53:500.
    doi: 10.1007/s11250-021-02956-0pubmed: 34613460google scholar: lookup
  31. Jaji AZ, Elelu N, Mahre MB, Jajere SM, Lawal JR, Bello AM, Mustapha FB. Herd growth parameters and constraints of camel rearing in Northeastern Nigeria.. Pastoralism 2017;7:16.
    doi: 10.1186/s13570-017-0089-xgoogle scholar: lookup
  32. Richardson JD, Cripps PJ, Lane JG. An Evaluation of the Accuracy of Ageing Horses by Their Dentition: Changes of Dental Morphology with Age.. Vet. Rec. 1995;137:117–121.
    doi: 10.1136/vr.137.5.117pubmed: 8533255google scholar: lookup
  33. Bello A, Sonfada ML, Umar AA, Umaru MA, Shehu SA, Hena SA, Onu JE, Fatima OO. Age Estimation of Camel in Nigeria Using Rostral Dentition.. Sci. J. Anim. Sci. 2013;2:9–14.
  34. Kemp GE, Causey OR, Moore DL, O’Connor EH. Viral Isolates from Livestock in Northern Nigeria: 1966–1970.. Am. J. Vet. Res. 1973;34:707–710.
    doi: 10.2460/ajvr.1973.34.05.707pubmed: 4634068google scholar: lookup
  35. World Health Organization . Rift Valley Fever in Niger. WHO; Geneva, Switzerland: 2016. [(accessed on 8 October 2025)]. Available online: https://www.who.int/emergencies/disease-outbreak-news/item/24-november-2016-rift-valley-fever-niger-en.
  36. Adamu AM, Allam L, Sackey AKB, Nma AB, Mshelbwala PP, Machunga-Mambula S, Idoko SI, Adikwu AA, Nafarnda WD, Garba BS. Risk factors for Rift Valley fever virus seropositivity in one-humped camels (Camelus dromedarius) and pastoralist knowledge and practices in Northern Nigeria.. One Health 2021;13:100340.
  37. Mahmoud HYAH, Ali AO. Epidemiology and serological detection of Rift Valley fever disease in farm animals in southern Egypt.. Onderstepoort J. Vet. Res. 2021;88:e1–e5.
    doi: 10.4102/ojvr.v88i1.1877pmc: PMC7876994pubmed: 33567844google scholar: lookup
  38. Kadja MC, Hamidou Ibrahim K, Onidje E, Sourokou Sabi S, Yahaya Mahamane A, Gagara H, Emikpe BO, Bada Alambedji R. Seroprevalence of Rift Valley Fever Virus Antibodies in Domestic Livestock in the Tahoua Region of Niger.. Vet. Ital. 2025;61:3.
    doi: 10.12834/VetIt.3743.34676.3pubmed: 40904027google scholar: lookup
  39. Muturi M, Akoko J, Nthiwa D, Chege B, Nyamota R, Mutiiria M, Maina J, Thumbi SM, Nyamai M, Kahariri S. Serological evidence of single and mixed infections of Rift Valley fever virus, Brucella spp., and Coxiella burnetii in dromedary camels in Kenya.. PLoS Negl. Trop. Dis. 2021;15:e0009275.
  40. Anyangu AS, Gould LH, Sharif SK, Nguku PM, Omolo JO, Mutonga D, Rao CY, Lederman ER, Schnabel D, Paweska JT. Risk factors for severe Rift Valley fever infection in Kenya, 2007.. Am. J. Trop. Med. Hyg. 2010;83:14–21.
    doi: 10.4269/ajtmh.2010.09-0293pmc: PMC2913492pubmed: 20682901google scholar: lookup
  41. Abdallah MM, Adam IA, Abdalla TM, Abdelaziz SA, Ahmed ME, Aradaib IE. A survey of Rift Valley fever and associated risk factors among the one-humped camel (Camelus dromedarius) in Sudan.. Ir. Vet. J. 2016;69:6.
    doi: 10.1186/s13620-016-0065-6pmc: PMC4901444pubmed: 27293548google scholar: lookup
  42. Tshilenge GM, Dundon WG, De Nardi M, Mulumba Mfumu LK, Rweyemamu M, Kayembe-Ntumba JM, Masumu J. Seroprevalence of Rift Valley fever virus in cattle in the Democratic Republic of the Congo.. Trop. Anim. Health Prod. 2019;51:537–543.
    doi: 10.1007/s11250-018-1721-5pubmed: 30350160google scholar: lookup

Citations

This article has been cited 0 times.